AbbVie Inc (ABBV)

Industry Drug Manufacturers - General


This stock can be held in an Investment ISA and an Investment Account
Sell

$262.24

Buy

$262.46

arrow-up$2.37 (+0.91%)

Prices updated at 02 Oct 2026, 19:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new ...
$262.42 - $257.87
$269.39 - $190.75
2.66
459,326.80m
73.43
-
2,766,517
-
6,348,699.15
0.02
1,838.68m
US00287Y1091
2.37
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.